NASDAQ · Biotechnology

SRPT (SRPT) Stock

$15.88 +6.86% NASDAQ: SRPT Healthcare

Valuation

MetricValue
Price$15.88
Market Cap$1.68B
P/E Ratio54.66
P/B Ratio1.34
P/S Ratio0.92
EPS (TTM)$-7.13
52-Week High$25.32
52-Week Low$10.42
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE4.91%
ROA0.02%
ROCE-57.67%
Gross Margin62.39%
Operating Margin-1.88%
Net Margin2.98%
Debt/Equity0.69
Current Ratio2.32

Annual Financials (USD)

Metric20212022202320242025
Revenue$702.0M$933.0M$1.2B$1.9B$2.2B
Operating Profit$-460.0M$-536.0M$-268.0M$218.0M$-658.0M
Net Profit$-419.0M$-703.0M$-536.0M$235.0M$-713.0M
EPS$-5.15$-8.03$-5.80$2.34$-7.13
Op Margin-65.5%-57.5%-21.5%11.5%-29.9%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$3.1B$3.1B$3.3B$4.0B$3.4B
Total Liabilities$2.2B$2.7B$2.4B$2.4B$2.2B
Cash$2.1B$967.0M$428.0M$1.1B$801.0M
Borrowings$1.2B$1.6B$1.4B$1.3B$1.0B

Latest News

SRPT Stock Slides 10% in a Week: Is Dyne Therapeutics a Threat? Zacks · Jul 22, 2026 Sarepta Therapeutics to Announce Second Quarter 2026 Financial Results Business Wire · Jul 22, 2026 SRPT: Lowering target price to $13.00 Argus Research · Jul 22, 2026 SRPT Stock Drops 4% As Citi Flags Potentially Stronger Rival In Duchenne Space Stocktwits · Jul 21, 2026 Sarepta Skids After A Rival Clears A Key Hurdle In The Duchenne Space Investor's Business Daily · Jul 20, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-443.0M$-325.0M$-501.0M$-206.0M$-205.0M
Investing Cash Flow$457.0M$-1.1B$-253.0M$609.0M$-32.0M
Financing Cash Flow$13.0M$-72.0M$125.0M$125.0M$-42.0M
Net Cash Flow$614.0M$-1.1B$-542.0M$675.0M$-304.0M
Free Cash Flow$-482.0M$-358.0M$-588.0M$-353.0M$-307.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.09
EV / EBITDA52.26
FCF Yield5.30%
Quick Ratio2.62
Interest Coverage-65.80
Return 1Y19.29%
Return 3Y-84.79%
Return 5Y-76.21%

Ownership

Insiders Held4.22%
Institutions Held99.57%
Institutions Float Held103.96%
Institutional HolderSharesReport Date
Blackrock Inc.14,755,2772026-03-31
Vanguard Portfolio Management LLC6,640,6922026-03-31
State Street Corporation6,613,3142026-03-31
AQR Capital Management, LLC6,433,1122026-03-31
Two Sigma Investments, LP4,593,1952026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ADPT $24.93 +5.64% -69.84 $3.99B 0.00%
AGIO $31.72 +0.38% -3.56 $1.89B 0.00%
BEAM $25.62 +2.19% -35.36 $2.64B 0.00%
COGT $42.27 -1.33% -34.70 $7.22B 0.00%
DNLI $24.42 +1.03% -6.20 $3.88B 0.00%

About SRPT

SRPT stock trades at $15.88 with a market capitalization of $1.68B. The stock is valued at a price-to-earnings (P/E) ratio of 54.66, price-to-book of 1.34, price-to-sales of 0.92. Over the past 52 weeks the stock has ranged between $10.42 and $25.32, and currently trades 37.3% below its 52-week high.

On profitability, SRPT generates a return on equity (ROE) of 4.91%, return on capital employed of -57.67%, an operating margin of -1.88%, a net profit margin of 2.98%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides